Tvardi Therapeutics TVRD
NASDAQ TVRD
$1.15 -0.09 (-7.26%)
At close: Oct 2, 2026 · 4:00 PM EDT

Tvardi Therapeutics (TVRD) Price to FCF (2014 - 2025)

Updated

Tvardi Therapeutics' (TVRD) Price to FCF stood at 5.46 in Q1 2025.

Analysis

Tvardi Therapeutics (TVRD) Price to FCF (2014 - 2025) Analysis & Trends

Starting with Q1 2014, Tvardi Therapeutics' Price to FCF history includes 6 quarters.

  • The Q1 2025 figure is the highest quarterly Price to FCF since Q3 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Tvardi Therapeutics 10.79 Mn 10.79 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 5.46
Sep 30, 2021 33.59
Jun 30, 2021 45.89
Mar 31, 2021 121.64
Jun 30, 2018 526.39
Mar 31, 2014 187.22
API Access

Tvardi Therapeutics Price to FCF API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-fcf&ticker=TVRD&period=max&api_key=YOUR_API_KEY